NABOTA, the botulinum toxin formulation of Daewoong Pharmaceutical, was named the World-Class Product of 2014
Daewoong
Pharmaceutical signed contracts worth KRW 700 billion to export NABOTA to about
60 countries, cementing its undisputed leadership position in global market
NABOTA
proved its potential for world’s top-selling product and Daewoong Pharmaceutical’s unrivaled technological prowess.
Daewoong Pharmaceutical
Co.,Ltd(President: Lee Jong-wook) announced on December 9 that NABOTA, a
botulinum toxin formulation developed with its own technology, was honored with
the World-Class Product designation in 2014 World-Class Product Award held in
COEX, Samseong-dong, Gangnam-gu. Seoul.
For more info please visit www.nabota.info
No comments:
Post a Comment